Matthew Pollman is listed as an executive officer and director on 4 SEC Form D filings by 2 issuers between Nov 2013 and Aug 2025: JUVENTAS THERAPEUTICS INC (Cleveland, OH — biotechnology — 2013–2017; $22.1M reported sold to 46 investors) and ValCor Cath Inc. (Ottawa Hills, OH — biotechnology — 2025; $4.25M reported sold to 52 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 12 years. Across those companies the filings report $26.3M sold in total.
Listed alongside George Arida (3 shared filings), Linda Tufts (3 shared filings), Rahul Aras (3 shared filings), Roger Newton (3 shared filings), Suzette Dutch (3 shared filings) and 10 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Matthew. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Matthew Pollman and found 6 differences: Form D filed 20 days after the first sale; Matthew Pollman's role changed at JUVENTAS THERAPEUTICS INC: director → executive officer, director; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.